Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results deaths Eviral clearance Ehospitalization or death E

COVID-19 prophylaxis meta-analysis

O'Brien (Part A: uninfected household contacts), 2021
 
NCT04452318
RCTcasirivimab and imdevimab (Ronapreve, REGN-COV2)placeboCOVID-19 prophylaxissome concern
1240/1235 conclusif
1 study excluded by filtering options (1 RCT / 0 OBS)

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).